₹1879.50
as on
as on September 4, 2025 at 4:01 pm IST
Day's Low
Day's High
1.31%
Downside
2.26%
Upside
52 Week's Low
52 Week's High
35.62%
Downside
19.61%
Upside
as on September 4, 2025 at 4:01 pm IST
Market Cap
₹21,748.34 Cr
Return on Equity (ROE)
0PE Ratio (TTM)
-241.91
Return on capital employed (ROCE)
0Industry PE ratio
42.24
Beta (LTM)
1.22
P/B Ratio
0Dividend Yield
0PEG Ratio
-3.96
Quarterly Earnings Growth YOY
-96.58
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
as on September 4, 2025 at 4:01 pm IST
OneSource Specialty Pharma Ltd in the last 5 years
Lowest (-279.97x)
June 30, 2025
Today (-241.91x)
September 3, 2025
Industry (42.24x)
September 3, 2025
Highest (-46.51x)
February 28, 2025
Today’s Price to Earnings Ratio: -241.91x
Compare market cap, revenue, PE, and other key metrics of OneSource Specialty Pharma Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
BUY | 21,748.34 | 2.21% | 0.80 | -392 | 171 | |
BUY | 16,426.13 | 61.13% | 0.51 | 461 | 1,694 | |
BUY | 5,234.08 | 13.79% | 0.63 | 128 | 1,243 | |
NA | 2,303.77 | 7.5% | 0.00 | 100 | 390 | |
NA | 7,969.18 | 41% | 0.57 | 216 | 1,852 |
Based on 4 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 4 analysts, 100% of analysts recommend a 'BUY' rating for OneSource Specialty Pharma Ltd. Average target price of ₹2480.25
Source: S&P Global Market Intelligence
Get share price movements and forecasts by analysts on OneSource Specialty Pharma Ltd.
What analysts predicted
30.61%UPSIDE
Target Price
₹2480.25
Current Price
₹1879.5
Analyzed by
4 Analysts
High
₹2529
Target
₹2480.25
Low
₹2417
OneSource Specialty Pharma Ltd target price ₹2480.25, a slight upside of 30.61% compared to current price of ₹1879.5. According to 4 analysts rating.
Source: S&P Global Market Intelligence
Search interest for OneSource Specialty Pharma Ltd Stock has decreased by -7% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
Numbers in percentages
Check out the Mutual Funds with significant holdings in OneSource Specialty Pharma Ltd.
View detailed summary of the earnings and dividend history of OneSource Specialty Pharma Ltd.
OneSource Specialty Pharma Ltd’s net profit jumped 96.58% since last year same period to ₹0.19Cr in the Q1 2025-2026. On a quarterly growth basis, OneSource Specialty Pharma Ltd has generated -100.19% fall in its net profits since last 3-months.
Read More about Earnings ResultsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
MF Holding Up
Mutual Funds have increased holdings from 8.32% to 9.06% in Jun 2025 quarter
Retail Holding Up
Retail Investor have increased holdings from 29.17% to 33.42% in Jun 2025 quarter
Price Rise
In the last 6 months, ONESOURCE stock has moved up by 37.4%
FII Holding Up
Foreign Institutions have increased holdings from 18.54% to 18.69% in Jun 2025 quarter
Promoter Holding Down
Promoters have decreased holdings from 34.25% to 29.79% in Jun 2025 quarter
Organisation | OneSource Specialty Pharma Ltd |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
OneSource Specialty Pharma Ltd share price today stands at ₹1879.5 as on at the close of the market. OneSource Specialty Pharma Ltd share today touched a day high of ₹1921.9 and a low of ₹1854.8.
OneSource Specialty Pharma Ltd touched a 52 week high of ₹2248 and a 52 week low of ₹1209.95. OneSource Specialty Pharma Ltd share price today i.e. is closed at ₹1879.5, which is -16.39% down from its 52 week high and 55.34% up from its 52 week low.
OneSource Specialty Pharma Ltd market capitalisation is ₹21,748.34 Cr as on .
To buy OneSource Specialty Pharma Ltd shares, you need to follow these steps:
OneSource Specialty Pharma Ltd trading volume is 2.04L as on . This means that 2.04L shares of OneSource Specialty Pharma Ltd were bought and sold on the stock market during today's trading session.